SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eitan A. Friedman, Martin L. Ogletree, Elias V. Haddad, Olivier Boutaud, Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease, Thrombosis Research, 2015,

    CrossRef

  2. 2
    Amin A. Nanji, Emily C. Liong, Jia Xiao, George L. Tipoe, Thromboxane Inhibitors Attenuate Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administrations, Alcoholism: Clinical and Experimental Research, 2013, 37, 1
  3. 3
    Michel Félétou, The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2011, 3, 4, 1

    CrossRef

  4. 4
    Michel Félétou, The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway", Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2011, 3, 4, 1

    CrossRef

  5. 5
    Michel Félétou, Paul M Vanhoutte, Tony J Verbeuren, The Thromboxane/Endoperoxide Receptor (TP): The Common Villain, Journal of Cardiovascular Pharmacology, 2010, 55, 4, 317

    CrossRef

  6. 6
    Michel Félétou, Richard A. Cohen, Paul M. Vanhoutte, Tony J. Verbeuren, Cardiovascular Pharmacology - Endothelial Control, 2010,

    CrossRef

  7. 7
    Marie Lordkipanidzé, Chantal Pharand, Donald A. Palisaitis, Jean G. Diodati, Aspirin resistance: Truth or dare, Pharmacology & Therapeutics, 2006, 112, 3, 733

    CrossRef

  8. 8
    Koichi NAKAYAMA, Mechanotransduction and Cellular Response—A Challenge toward Development of Mechano-pharmacology, YAKUGAKU ZASSHI, 2006, 126, 8, 565

    CrossRef

  9. 9
    Jie Yang, Wei-Yi Hua, Fu-Xiang Wang, Zhi-Yuan Wang, Xiang Wang, Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives, Bioorganic & Medicinal Chemistry, 2004, 12, 24, 6547

    CrossRef

  10. 10
    JA Whitworth, Emerging drugs in the management of hypertension, Expert Opinion on Emerging Drugs, 2003, 8, 2, 377

    CrossRef

  11. 11
    Hiroshi Marusawa, Hiroyuki Setoi, Akihiko Sawada, Akio Kuroda, Jiro Seki, Yukio Motoyama, Hirokazu Tanaka, Synthesis and Biological Activity of 1-Phenylsulfonyl-4-Phenylsulfonylaminopyrrolidine Derivatives as Thromboxane A2 Receptor Antagonists, Bioorganic & Medicinal Chemistry, 2002, 10, 5, 1399

    CrossRef